Listar por autor "Castillo E."
Mostrando ítems 1-3 de 3
-
Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]
Castillo E.; Prada-Arismendy J. (2019) -
Microarray based on comparative genomic hybridization reveals new recurrent genetic aberrations in acute myeloid leukemia
Prada-Arismendy J.; Lopez-Rivera J.J.; Carrillo Y.; Castillo E.; Castellanos W. (2018) -
The reduction of the expression of B-catenin and c-Myc is related to a better outcome in patients with AML
Cardona A.; Prada-Arismendy J.; Castillo E.; Arroyave J.C. (2018)